Ashley Cordova - 04 Mar 2026 Form 4 Insider Report for NovoCure Ltd (NVCR)

Reporting relationship: Former Chief Executive Officer
Issuer ticker: NVCR
Reported as of: 04 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2026, 16:33:25 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: Steven Robbins, as attorney in fact for Cordova, Ashley

Key filing fact

Ashley Cordova filed Form 4 for NovoCure Ltd (NVCR) on 05 Mar 2026.

Key facts

This page summarizes Ashley Cordova's Form 4 filing for NovoCure Ltd (NVCR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Mar 2026, 16:33.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001822014 Primary reporting owner

Cordova Ashley

Relationship: Former Chief Executive Officer
Address: C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE
Signature: Steven Robbins, as attorney in fact for Cordova, Ashley
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVCR transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -17,638
Change %: -4%
Price: $13.30^*
Shares after: 422,570
Date: 04 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ashley Cordova is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).